A multi-institutional tech group spearheaded by Arizona State University invested $1.5 million into eight startup companies ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results